pharmallittle

Pharmalot By Ed Silverman

Pharmalittle: Wholesalers near deal over opioid litigation; pharma gives $67,400 to Peters for trying to torpedo drug pricing bill

Pharmalot By Ed Silverman

Pharmalittle: FDA panel backs Amgen osteoporosis drug; campaign launched to tank a Trump Medicare proposal

Pharmalot By Ed Silverman

Pharmalittle: Teva faces setback in new migraine drug market; prices for valsartan jump in the U.S.

Pharmalot By Elizabeth Cooney

Pharmalittle: Medicare could save with generic combos; an overlooked CAR-T component

Pharmalot By Ed Silverman

Pharmalittle: Novo may drop insulin prices; Teva employees push back against cuts